However, some studies have reported that the luminal A/B classification does not fully distinguish the heterogeneity in ER (+) and/or PR (+) and HER2 (−) breast cancer (Gatza et al., 2014; Netanely et al., 2016; Zhu et al., 2019). The gene discussed is ESR1; the disease is breast cancer.